Articles tagged with Radiation Therapy
A study conducted by University of California San Francisco expert Mac Roach found that high-risk prostate cancer patients who receive hormonal therapy in conjunction with radiotherapy have a 20% higher survival rate after eight years compared to those receiving radiotherapy alone. This suggests that prostate cancer patients may need t...
Researchers found that combining low doses of angiostatin with standard radiation therapy improves response rates without increasing toxicity. The combination causes significant growth inhibition in animal models, even in mice with large tumors.
A new study by Duke University Medical Center found that a combination of intensive, twice-daily radiation therapy and simultaneous chemotherapy can control cancer more frequently. The treatment resulted in a significant improvement in disease control and patient survival rates.
Researchers at St. Jude Children's Research Hospital are developing new brain tumor treatment protocols that use 3D imaging to accurately target tumors, reducing radiation doses and side effects. The protocols involve combining lower-dose radiation with chemotherapy to increase survival rates and minimize long-term damage.
Researchers have found that radiation exposure can be passed down through generations, affecting cell growth and reproduction. The study used a sensitive model to demonstrate that male mice exposed to radiation may pass on detrimental effects to their children, grandchildren, and great-grandchildren.
A recent study published in the American Society for Therapeutic Radiology and Oncology found that children with soft tissue sarcomas who did not respond well to chemotherapy can benefit from radiation therapy. The treatment was shown to improve survival rates by up to 40% in this patient population.
Researchers at the University of Pennsylvania School of Medicine have identified a novel death-receptor gene called KILLER/DR5 that responds to chemotherapy and radiation by killing cancer cells. The discovery provides new insights into how cancer cells are killed after treatment, with potential implications for improving cancer therapy.
Researchers will present studies on permanent prostate implants and radiation therapy for various cancers, including prostate cancer, lung cancer, and cervical cancer. The presentation highlights the benefits of these treatments in improving survival rates and quality of life for patients.
Researchers at Brown University have developed a drug and radiation regimen that demonstrates substantial activity in reducing locally advanced and inoperable tumors in the pancreas and stomach.
A new clinical trial has shown that combining chemotherapy with radiation therapy can improve the survival rate of patients with nasopharyngeal carcinoma by 31% compared to radiation alone. The treatment, which included cisplatin and 5-fluorouracil, resulted in a three-year survival rate of 76% for those receiving the combination therapy.